Patents by Inventor Vipul Dave

Vipul Dave has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11911478
    Abstract: Compositions useful in the treatment of cough and cold symptoms, including but not limited to, cough, nasal congestion and sore throat, are disclosed.
    Type: Grant
    Filed: December 7, 2020
    Date of Patent: February 27, 2024
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Gerard P. McNally, Anurag Pandey, Vipul Dave
  • Publication number: 20240024355
    Abstract: The present invention is directed to an orally disintegrable multi-layered particle comprising a hydrophobic core containing simethicone, a hydrophilic surfactant layer, and a hydrophilic disintegrant layer; wherein said hydrophilic surfactant layer is located between the hydrophobic core and the hydrophilic disintegrant layer; and orally disintegrable solid dosage forms comprising said multi-layered particle, and related processes.
    Type: Application
    Filed: October 25, 2021
    Publication date: January 25, 2024
    Inventors: Anurag PANDEY, Vipul DAVE
  • Publication number: 20220347449
    Abstract: A transdermal delivery device includes a film having first and second outwardly facing major surfaces; at least one liquid reservoir contained within the film; at least one microfluidic channel having a transverse dimension between about 100 nm and 0.5 mm disposed within the film and in fluid communication with the at least one liquid reservoir; and at least one outlet port associated with at least one microneedle operatively connected to the first outwardly facing major surface of the film in fluid communication with the at least one microfluidic channel.
    Type: Application
    Filed: July 14, 2022
    Publication date: November 3, 2022
    Inventors: Marc Alary, Bharat Patel, Peyton Hopson, Jan-Joo Liu, Vipul Davé
  • Publication number: 20220331294
    Abstract: The invention relates to a gel-chewable dosage form comprising a first active pharmaceutical ingredient encapsulated in a lipid material that is embedded in the gel-chewable dosage form and wherein the gel-chewable dosage form comprises at least a second active pharmaceutical ingredient as well as a method of treating a subject suffering from a disease or disorder in the gastro intestinal tract using the gel-chewable dosage form.
    Type: Application
    Filed: September 15, 2020
    Publication date: October 20, 2022
    Inventors: Vipul DAVE, Anurag PANDEY
  • Patent number: 11464955
    Abstract: A dermal delivery device includes a film having first and second outwardly facing major surfaces; at least one liquid reservoir contained within the film; at least one microfluidic channel having a transverse dimension between about 100 nm and 0.5 mm disposed within the film and in fluid communication with the at least one liquid reservoir; and at least one outlet port operatively connected to the first outwardly facing major surface of the film in fluid communication with the at least one microfluidic channel.
    Type: Grant
    Filed: June 28, 2019
    Date of Patent: October 11, 2022
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Marc Alary, Bharat Patel, Peyton Hopson, Jan-Joo Liu, Vipul Davé
  • Patent number: 11413440
    Abstract: A transdermal delivery device includes a film having first and second outwardly facing major surfaces; at least one liquid reservoir contained within the film; at least one microfluidic channel having a transverse dimension between about 100 nm and 0.5 mm disposed within the film and in fluid communication with the at least one liquid reservoir; and at least one outlet port associated with at least one microneedle operatively connected to the first outwardly facing major surface of the film in fluid communication with the at least one microfluidic channel.
    Type: Grant
    Filed: June 28, 2019
    Date of Patent: August 16, 2022
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Marc Alary, Bharat Patel, Peyton Hopson, Jan-Joo Liu, Vipul Davé
  • Publication number: 20220062173
    Abstract: The present invention relates to a pharmaceutical liquid composition, wherein said liquid composition comprises at least one cooling agent comprising of a phenyl ring containing a polar side group at least one viscosity enhancing agent and at least one surfactant. The invention also relates to a method to produce such a pharmaceutical composition as well as a method of alleviating a symptom selected from the group consisting of cough, nasal congestion and sore throat in a subject comprising administering the composition according to any of preceding claims.
    Type: Application
    Filed: December 12, 2019
    Publication date: March 3, 2022
    Inventors: Gerard P. McNally, Vipul Dave, Anurag Pandey
  • Publication number: 20210401739
    Abstract: The invention relates to a soft chewable dosage form comprising a first active pharmaceutical ingredient encapsulated in a lipid material that is embedded in the soft chewable dosage form and wherein the soft chewable dosage form comprises at least a second active pharmaceutical ingredient as well as a method of treating a subject suffering from a disease or disorder in the gastro intestinal tract using the soft chewable dosage form.
    Type: Application
    Filed: September 13, 2021
    Publication date: December 30, 2021
    Inventors: Gregory E. Koll, Gerard P. McNally, Vipul Dave
  • Publication number: 20210378968
    Abstract: An improved customizable dosage form comprising a substrate, such as a tablet core, that has two or more distinct, discrete cavities on opposing sides of its exterior surface; and/or two or more distinct, discrete cavities on a first side of its exterior surface and an identification feature on a second opposing side of its exterior surface. A process for making such a customizable dosage form wherein one or more active ingredients and inactive ingredients such as colors, flavors and/or sensates are deposited into at least one of the cavities.
    Type: Application
    Filed: May 18, 2021
    Publication date: December 9, 2021
    Inventors: Matthew A. Howard, Peyton Hopson, Joshua Sinsel, Anthony Bean, Vipul Dave
  • Patent number: 11141375
    Abstract: The invention relates to a soft chewable dosage form comprising a first active pharmaceutical ingredient encapsulated in a lipid material that is embedded in the soft chewable dosage form and wherein the soft chewable dosage form comprises at least a second active pharmaceutical ingredient as well as a method of treating a subject suffering from a disease or disorder in the gastro intestinal tract using the soft chewable dosage form.
    Type: Grant
    Filed: October 16, 2019
    Date of Patent: October 12, 2021
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Gregory E. Koll, Gerard P. McNally, Vipul Dave
  • Publication number: 20210093723
    Abstract: Compositions useful in the treatment of cough and cold symptoms, including but not limited to, cough, nasal congestion and sore throat, are disclosed.
    Type: Application
    Filed: December 7, 2020
    Publication date: April 1, 2021
    Inventors: Gerard P. McNally, Anurag Pandey, Vipul Dave
  • Publication number: 20210045421
    Abstract: The present invention discloses a nutritional dietary formulation with an appropriate weight of weeds comprising whole weed Amaranthus retroflexus (pigweed), whole weed Taraxacum officinale (dandelion) excluding unwanted parts of the roots, whole weed Urtica dioica (stinging nettles) excluding its nettles, and whole weed Chenopodium album (lamb's quarters), in the ratio of 5:4:2:4 and corn meal in amount of 250 grams. It is prepared from ubiquitously available and otherwise discarded weeds and cornmeal. Thus, it is economical. Further, it is a wholesome meal that supplies calories both quantitatively and qualitatively. The micronutrients are also balanced. The present invention provides dietary nutritional formulations that meet the Recommended Dietary Allowance (RDA) of all types of human groups including the healthy human beings and under nourished human population.
    Type: Application
    Filed: May 29, 2018
    Publication date: February 18, 2021
    Inventor: Mughda Vipul Dave
  • Patent number: 10888620
    Abstract: Compositions useful in the treatment of cough and cold symptoms, including but not limited to, cough, nasal congestion and sore throat, are disclosed.
    Type: Grant
    Filed: November 28, 2017
    Date of Patent: January 12, 2021
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Gerard P. McNally, Anurag Pandey, Vipul Dave
  • Publication number: 20200121594
    Abstract: The invention relates to a soft chewable dosage form comprising a first active pharmaceutical ingredient encapsulated in a lipid material that is embedded in the soft chewable dosage form and wherein the soft chewable dosage form comprises at least a second active pharmaceutical ingredient as well as a method of treating a subject suffering from a disease or disorder in the gastro intestinal tract using the soft chewable dosage form.
    Type: Application
    Filed: October 16, 2019
    Publication date: April 23, 2020
    Inventors: Gregory E. Koll, Gerard P. McNally, Vipul Dave
  • Publication number: 20200001065
    Abstract: A transdermal delivery device includes a film having first and second outwardly facing major surfaces; at least one liquid reservoir contained within the film; at least one microfluidic channel having a transverse dimension between about 100 nm and 0.5 mm disposed within the film and in fluid communication with the at least one liquid reservoir; and at least one outlet port associated with at least one microneedle operatively connected to the first outwardly facing major surface of the film in fluid communication with the at least one microfluidic channel.
    Type: Application
    Filed: June 28, 2019
    Publication date: January 2, 2020
    Inventors: Marc Alary, Bharat Patel, Peyton Hopson, Jan-Joo Liu, Vipul Davé
  • Publication number: 20200001064
    Abstract: A dermal delivery device includes a film having first and second outwardly facing major surfaces; at least one liquid reservoir contained within the film; at least one microfluidic channel having a transverse dimension between about 100 nm and 0.5 mm disposed within the film and in fluid communication with the at least one liquid reservoir; and at least one outlet port operatively connected to the first outwardly facing major surface of the film in fluid communication with the at least one microfluidic channel.
    Type: Application
    Filed: June 28, 2019
    Publication date: January 2, 2020
    Inventors: Marc Alary, Bharat Patel, Peyton Hopson, Jan-Joo Liu, Vipul Davé
  • Publication number: 20170354606
    Abstract: In one aspect the present invention features process for making a tablet comprising at least one pharmaceutically active agent, said method comprising the step of applying radiofrequency energy to a powder blend to sinter said powder blend into said tablet, wherein said powder blend comprises lossy coated particles and said at least one pharmaceutically active agent, wherein said lossy coated particles comprises a substrate that is at least partially coated with a lossy coating comprising at least one activator, wherein said substrate has a Q value of greater than 100 and said activator has a Q value of less than 75.
    Type: Application
    Filed: August 29, 2017
    Publication date: December 14, 2017
    Inventors: Christopher E. Szymczak, Vipul Dave, Gerard P. McNally, David B. Cochran, Gregory Koll, Stephen Ulrich
  • Patent number: 9789066
    Abstract: In one aspect the present invention features process for making a tablet comprising at least one pharmaceutically active agent, said method comprising the step of applying radiofrequency energy to a powder blend to sinter said powder blend into said tablet, wherein said powder blend comprises lossy coated particles and said at least one pharmaceutically active agent, wherein said lossy coated particles comprises a substrate that is at least partially coated with a lossy coating comprising at least one activator, wherein said substrate has a Q value of greater than 100 and said activator has a Q value of less than 75.
    Type: Grant
    Filed: January 8, 2015
    Date of Patent: October 17, 2017
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Christopher E. Szymczak, Vipul Dave, Gerard P. McNally, David B. Cochran, Gregory Koll, Stephen Ulrich
  • Patent number: 9511554
    Abstract: Biocompatible materials may be configured into any number of implantable medical devices including intraluminal stents. The biocompatible material may comprise metallic and non-metallic materials in hybrid structures. In one such structure, a device may be fabricated with one or more elements having an inner metallic frame that is not degradable with an outer shell formed from a polymeric material that is biodegradable by extrusion blow molding. Additionally, therapeutic agents may be incorporated into the microstructure or the bulk material.
    Type: Grant
    Filed: January 23, 2013
    Date of Patent: December 6, 2016
    Assignee: CARDINAL HEALTH SWITZERLAND 515 GmbH
    Inventor: Vipul Dave
  • Publication number: 20150196493
    Abstract: In one aspect the present invention features process for making a tablet comprising at least one pharmaceutically active agent, said method comprising the step of applying radiofrequency energy to a powder blend to sinter said powder blend into said tablet, wherein said powder blend comprises lossy coated particles and said at least one pharmaceutically active agent, wherein said lossy coated particles comprises a substrate that is at least partially coated with a lossy coating comprising at least one activator, wherein said substrate has a Q value of greater than 100 and said activator has a Q value of less than 75.
    Type: Application
    Filed: January 8, 2015
    Publication date: July 16, 2015
    Inventors: Christopher E. Szymczak, Vipul Dave, Gerard P. McNally, David B. Cochran, Gregory Koll, Stephen Ulrich